Literature DB >> 15084447

High-fat diet induced adiposity in mice with targeted disruption of the dopamine-3 receptor gene.

John-Andrews McQuade1, Stephen C Benoit, Ming Xu, Stephen C Woods, Randy J Seeley.   

Abstract

Dopamine (DA) signaling has been implicated in the control of energy balance and ingestive behavior. In the present study, we sought to characterize body weight, body fat and food intake regulation in a mouse with a targeted disruption of the dopamine-3 receptor gene (Drd3). In the first set of experiments male and female wild-type and mutant (Drd3-/-) mice were given access to two different diets varying in fat content. Body weight, food intake, carcass analysis and plasma levels of leptin and insulin were measured. Male Drd3-/- mice have increased body weight and body fat when given access to high fat (HF) diet but not standard rodent chow. The female Drd3-/- mice did not demonstrate increased body weight when given access to either diet, but did have increased body fat on both diets. Plasma leptin and insulin levels reflected the increased adiposity demonstrated in each genotype and gender. These findings suggest the D3-R signaling is involved in the regulation of body weight and body fat when mice are given access to diets differing in palatability and fat content. Copyright 2003 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15084447     DOI: 10.1016/j.bbr.2003.09.034

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  11 in total

1.  Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior.

Authors:  Anne Stößel; Regine Brox; Nirupam Purkayastha; Harald Hübner; Carsten Hocke; Olaf Prante; Peter Gmeiner
Journal:  Bioorg Med Chem       Date:  2017-04-29       Impact factor: 3.641

Review 2.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

3.  Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.

Authors:  Xiaoyan Wang; Fengmin Li; Pedro A Jose; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

4.  Inhibitory effect of the D(3) dopamine receptor on insulin receptor expression and function in vascular smooth muscle cells.

Authors:  Hefei Huang; Yu Han; Xiaoyan Wang; Caiyu Chen; Changqing Yu; Duofen He; Hongyong Wang; Lin Zhou; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Am J Hypertens       Date:  2011-03-17       Impact factor: 2.689

5.  Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.

Authors:  Anne Marie D Axel; Jens D Mikkelsen; Henrik H Hansen
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

6.  Different effects of hyperlipidic diets in human lactation and adulthood: growth versus the development of obesity.

Authors:  Marià Alemany
Journal:  Reprod Biol Endocrinol       Date:  2011-07-28       Impact factor: 5.211

Review 7.  Dopaminergic Pathways in Obesity-Associated Inflammation.

Authors:  Fernanda Leite; Laura Ribeiro
Journal:  J Neuroimmune Pharmacol       Date:  2019-07-17       Impact factor: 4.147

8.  The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Donna M Platt; Amy H Newman; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2009-06-10       Impact factor: 4.530

9.  The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity.

Authors:  Panayotis K Thanos; Michael Michaelides; Christopher W Ho; Gene-Jack Wang; Amy H Newman; Christian A Heidbreder; Charles R Ashby; Eliot L Gardner; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2008-02-08       Impact factor: 3.533

10.  Dopamine D2 receptor upregulates leptin and IL-6 in adipocytes.

Authors:  Xiaoyan Wang; Van Anthony Villar; Andrew Tiu; Kiran K Upadhyay; Santiago Cuevas
Journal:  J Lipid Res       Date:  2018-02-22       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.